Mike Kelly sold CVS Health Corp (NYSE: CVS)
Mike Kelly (R-PA), a U.S. Representative, has disclosed 1 trade in CVS Health Corp (CVS) since 2016, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Mike Kelly sold $1,001 - $15,000 of CVS Health Corp (NYSE: CVS) on November 8, 2016. Since that trade, CVS is up +92.70% against the S&P 500 up +303.59%, an outperformance of -210.89%.
Data updated
Mike Kelly's CVS trades vs the price
CVS is up +92.70% since Mike Kelly sold on November 8, 2016, versus +303.59% for the S&P 500.
Performance since this trade
All Mike Kelly CVS trades
Mike Kelly & CVS trading FAQ
Is it legal for Mike Kelly to trade CVS Health Corp (CVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CVS Health Corp (CVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Mike Kelly sell CVS?
Mike Kelly disclosed a sale of $1,001 - $15,000 of CVS Health Corp (CVS) on November 8, 2016, according to public STOCK Act filings.
How has CVS performed since Mike Kelly's trade?
Since Mike Kelly sold CVS on November 8, 2016, the stock is up +92.70%, versus +303.59% for the S&P 500 over the same period, an outperformance of -210.89%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CVS trades?
Quantellect tracks every disclosed congressional trade in CVS Health Corp (CVS) on the CVS Health Corp congressional trading page, which aggregates filings across all members of Congress.
Mike Kelly's CVS tradesAll congressional filings for CVS Health CorpMike Kelly's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.